Correlation Engine 2.0
Clear Search sequence regions


  • CFTR (2)
  • CXCL1 (2)
  • cystic fibrosis (8)
  • expressed genes (3)
  • HSPA1A (1)
  • humans (1)
  • ICAM1 (1)
  • KCNE1 (1)
  • patients (3)
  • prognosis (1)
  • SLC9A3R2 (1)
  • STX1A (1)
  • TNFRSF11A (1)
  • TNFRSF1A (1)
  • Sizes of these terms reflect their relevance to your search.

    Cystic fibrosis (CF) is an autosomal recessive disease caused by CFTR gene mutations. Despite having the same mutation, CF patients may demonstrate clinical variability in severity and prognosis of the disease. In this study, we aimed to determine differentially expressed genes between mild and severe siblings with same genotype. We performed targeted real-time polymerase chain reaction based transcriptomic analysis of nasal epithelial cells obtained from two families with two siblings with Class II mutations (F508del/F508del) and (F508del/G85E), one family with three siblings with Class IV mutation (I1234V/I1234V). In severe siblings with Class II mutations, TNFRSF11A, KCNE1, STX1A, SLC9A3R2 were found to be up regulated. CXCL1, CFTR, CXCL2 were found to be down regulated. In the severe sibling with Class IV mutation; mainly genes responsible from complement and coagulation system were identified. Comparison of CF patients to non-CF control; showed that ICAM1 was up regulated whereas EZR, TNFRSF1A, HSPA1A were down regulated in patients. As a result of this study, differentially expressed genes responsible for clinical severity among affected siblings carrying the same mutation were identified. The results will provide an opportunity for the development of novel target molecules for treatment of disease. © 2020 Wiley Periodicals LLC.

    Citation

    İlksen Berfin Ekinci, Mina Hızal, Nagehan Emiralioğlu, Uğur Özçelik, Ebru Yalçın, Deniz Doğru, Nural Kiper, Didem Dayangaç-Erden. Differentially expressed genes associated with disease severity in siblings with cystic fibrosis. Pediatric pulmonology. 2021 May;56(5):910-920

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33369261

    View Full Text